Skip to Main Content

Paper Details

Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
Front Immunol
3
2023
Author NameAffiliation
Lixia DiaoThe University of Texas MD Anderson Cancer Center
Laura A GibsonThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2